Atom Investors’s Amedisys AMED Stock Holding History

Atom Investors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,136	Closed	-$2.97M	–	589
2025 Q2	$2.97M	Buy	+30,136	New	+$2.85M	0.26%	109
2024 Q2	–	Sell	-2,214	Closed	-$204K	–	475
2024 Q1	$204K	Buy	+2,214	New	+$207K	0.03%	482
2022 Q1	–	Sell	-3,184	Closed	-$515K	–	196
2021 Q4	$515K	Buy	+3,184	New	+$512K	0.09%	162
2020 Q4	–	Sell	-11,185	Closed	-$2.64M	–	371
2020 Q3	$2.64M	Buy	+11,185	New	+$2.54M	0.25%	93
2019 Q2	–	Sell	-3,320	Closed	-$409K	–	401
2019 Q1	$409K	Buy	+3,320	New	+$417K	0.03%	371

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Atom Investors's AMED Position: Q3 2025 in Review

Atom Investors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 30,136 shares — an estimated $2.97M sold.

Atom Investors first reported a position in AMED in Q1 2019 and held it in 5 quarters. The position peaked at $2.97M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Atom Investors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Atom Investors sold 30,136 Amedisys shares in Q3 2025, an estimated $2.97M.
Atom Investors first reported a position in Amedisys in Q1 2019 and held it in 5 quarters.
Atom Investors's Amedisys position peaked at $2.97M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.